Lone Star Funds to Acquire Lonza’s Capsules & Health Ingredients Division
Event summary
- Lone Star Funds has agreed to acquire the Capsules & Health Ingredients (CHI) division of Lonza Group AG, with Lonza retaining a 40% equity stake.
- CHI operates globally with three segments: Hard Empty Capsules, Dosage Form Solutions, and Health Ingredients.
- The transaction is subject to customary closing conditions and approvals.
- Lone Star believes CHI will benefit from greater strategic flexibility and dedicated investment as an independent operator.
The big picture
Lone Star Funds’ acquisition of Lonza’s CHI division highlights the private equity firm’s strategy to invest in high-quality, globally recognized platforms with strong technical capabilities. The deal underscores the growing trend of private equity firms acquiring specialized healthcare and nutraceutical assets to drive operational improvements and strategic growth. With Lonza retaining a significant equity stake, the transaction also reflects a collaborative approach to leveraging existing customer relationships and market positions.
What we're watching
- Operational Focus
- How CHI’s operational performance will improve as an independent entity under Lone Star’s ownership.
- Growth Initiatives
- The pace at which CHI will pursue strategic growth initiatives across its core segments.
- Market Dynamics
- Whether CHI can sustain its leading positions in attractive markets with strong demand growth trends.
Related topics